cb-012
caribou
['cb-012', 'cll', 'caribou']
caribou biosciences presents new preclinical data on cb-012, an allogeneic anti-cll-1 car-t cell therapy, at the 2023 aacr annual meeting $crbu 
Real-Time News, Market Data and Stock Quotes for Biotech, Pharma, and Healthcare Stocks